Mitsumasa Kishimoto

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Tomoyuki Asano

Fukushima Medical University

JAPAN

View details

Keisuke Ono

Kyorin University

JAPAN

View details

Tae-Hwan Kim

SOUTH KOREA

View details

Ken Nagahata

Sapporo Medical University

JAPAN

View details

Noriyuki Takahashi

Designated Lecturer

Nagoya University Graduate School of Medicine

JAPAN

View details

Naomi Tsuchida

Yokohama City University Medical Center

JAPAN

View details

Hiromu Ito

Associate Professor

Kyoto University

JAPAN

View details

Hisashi Yamanaka

Professor

Tokyo Women's Medical University

JAPAN

View details

Yuri Uchiyama

Assistant professor

Yokohama City University Medical Center

JAPAN

View details

Shigeto Kobayashi

Juntendo University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mitsumasa Kishimoto

Research Interests

Explore related searches

Contact this professor

Articles (10)

Response to: ‘Correspondence on ‘Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial’’ by Zhao and Huang

Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication

Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome

Clinical Images: Impending cardiac tamponade and coated aorta in <scp>Erdheim‐Chester</scp> disease

Brodalumab, an anti–interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study

Socioeconomic impact of treatment with biological disease–modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis

Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis

Collaborators (10)

Tomoyuki Asano

Keisuke Ono

Tae-Hwan Kim

Ken Nagahata

Noriyuki Takahashi

Naomi Tsuchida

Hiromu Ito

Hisashi Yamanaka

Yuri Uchiyama

Shigeto Kobayashi

Make your next move.